Heparanase expression of glioma in human and animal models: Laboratory investigation

Journal of Neurosurgery

Volumn 113, Issue 2, 2010, Pages 261-269

  Hong, Xin ^a   Nelson, Kevin K ^a   DeCarvalho, Ana C ^a   Kalkanis, Steven N ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Animal model; Glioma; Heparanase

Indexed keywords

CD44V ANTIGEN; CELL ADHESION MOLECULE; HEPARANASE; KI 67 ANTIGEN; MESSENGER RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER INVASION; CANCER SURGERY; CELL INFILTRATION; CELL MEMBRANE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD44; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLUCURONIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; OLIGODENDROGLIOMA; RATS; RATS, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 77955652400     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.9.JNS09682     Document Type: Article

References (53)

1. Beckhove P, Helmke BM, Ziouta Y, Bucur M, Dorner W, Mogler C, et al: Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Clin Cancer Res 11:2899-2906, 2005
2. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG: Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046-1069, 2004
3. Ben-Zaken O, Gingis-Velitski S, Vlodavsky I, Ilan N: Heparanase induces Akt phosphorylation via a lipid raft receptor. Biochem Biophys Res Commun 361:829-834, 2007
4. Bogler O, Huang HJ, Cavenee WK: Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res 55:2746-2751, 1995
5. Bogler O, Nagane M, Gillis J, Huang HJ, Cavenee WK: Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro. Cell Growth Differ 10:73-86, 1999
6. Chang XZ, Wang ZM, Yu JM, Tian FG, Jin W, Zhang Y, et al: Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides. Clin Exp Metastasis 24:25-38, 2007
7. Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, et al: Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 118:1609-1617, 2006
8. Cohen-Kaplan V, Naroditsky I, Zetser A, Ilan N, Vlodavsky I, Doweck I: Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer 123:2566-2573, 2008
9. Dafni H, Cohen B, Ziv K, Israely T, Goldshmidt O, Nevo N, et al: The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice. Neoplasia 7:224-233, 2005
10. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I: Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 96:1219-1230, 2004
11. Fux L, Feibish N, Cohen-Kaplan V, Gingis-Velitski S, Feld S, Geffen C, et al: Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling. Cancer Res 69:1758-1767, 2009
12. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39:235-252, 1996
13. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N: Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279:23536-23541, 2004
14. Gohji K, Hirano H, Okamoto M, Kitazawa S, Toyoshima M, Dong J, et al: Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 95:295-301, 2001
15. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, Friedmann Y, et al: Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc Natl Acad Sci U S A 99:10031-10036, 2002
16. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang X, Zheng X, et al: Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells. J Exp Clin Cancer Res 27:23, 2008
17. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, et al: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett 236:39-45, 2006
18. Hostettler N, Naggi A, Torri G, Ishai-Michaeli R, Casu B, Vlodavsky I, et al: P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins. FASEB J 21:3562-3572, 2007
19. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5:803-809, 1999
20. Ilan N, Elkin M, Vlodavsky I: Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38:2018-2039, 2006 (Pubitemid 44397619)
21. Irimura T, Nakajima M, Nicolson GL: Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells. Biochemistry 25:5322-5328, 1986
22. Jin L, Nakajima M, Nicolson GL: Immunochemical localization of heparanase in mouse and human melanomas. Int J Cancer 45:1088-1095, 1990
23. Katz BZ, Ishai-Michaeli R, Zusman T, Vlodavsky I, Witz IP: Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage. Invasion Metastasis 14:276-289, 1994
24. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987
25. Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y, et al: High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 63:8749-8756, 2003
26. Kelly T, Suva LJ, Huang Y, Macleod V, Miao HQ, Walker RC, et al: Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res 65:5778-5784, 2005
27. Khoshyomn S, Penar PL, Wadsworth MP, Taatjes DJ: Localization of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy. Ultrastruct Pathol 21:517-525, 1997
28. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK: Glioblastoma, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System, ed 2. Lyon: IARC Press, 2000, pp 29-39
29. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, et al: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 61:4655-4659, 2001 (Pubitemid 32691870)
30. Komatsu N, Waki M, Sue M, Tokuda C, Kasaoka T, Nakajima M, et al: Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies. J Immunol Methods 331:82-93, 2008
31. Kosir MA, Foley-Loudon PA, Finkenauer R, Tennenberg SD: Multiple heparanases are expressed in polymorphonuclear cells. J Surg Res 103:100-108, 2002
32. Lapierre F, Holme K, Lam L, Tressler RJ, Storm N, Wee J, et al: Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 6:355-366, 1996
33. Lewis KD, Robinson WA, Millward MJ, Powell A, Price TJ, Thomson DB, et al: A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs 26:89-94, 2008
34. Liu CJ, Lee PH, Lin DY, Wu CC, Jeng LB, Lin PW, et al: Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol 50:958-968, 2009
35. Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I: Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer 83:424-431, 1999
36. Mollinedo F, Nakajima M, Llorens A, Barbosa E, Callejo S, Gajate C, et al: Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J 327:917-923, 1997
37. Nakajima M, Irimura T, Nicolson GL: Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells. Cancer Lett 31:277-283, 1986 (Pubitemid 16091018)
38. Nobuhisa T, Naomoto Y, Ohkawa T, Takaoka M, Ono R, Murata T, et al: Heparanase expression correlates with malignant potential in human colon cancer. J Cancer Res Clin Oncol 131:229-237, 2005
39. Roy M, Marchetti D: Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem 106:200-209, 2009
40. Sato T, Yamaguchi A, Goi T, Hirono Y, Takeuchi K, Katayama K, et al: Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. J Surg Oncol 87:174-181, 2004
41. Silbergeld DL, Chicoine MR: Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86:525-531, 1997
42. Takahashi H, Ebihara S, Okazaki T, Asada M, Sasaki H, Yamaya M: A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity. Br J Pharmacol 146:333-343, 2005
43. Takaoka M, Naomoto Y, Ohkawa T, Uetsuka H, Shirakawa Y, Uno F, et al: Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab Invest 83:613-622, 2003
44. Ueno Y, Yamamoto M, Vlodavsky I, Pecker I, Ohshima K, Fukushima T: Decreased expression of heparanase in glioblastoma multiforme. J Neurosurg 102:513-521, 2005
45. Uno F, Fujiwara T, Takata Y, Ohtani S, Katsuda K, Takaoka M, et al: Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res 61:7855-7860, 2001
46. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, et al: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793-802, 1999
47. Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, Elkin M, et al: Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12:121-129, 2002
48. Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, Vigoda M, et al: Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 14:290-302, 1994
49. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N: Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 66:1455-1463, 2006
50. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N: Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res 63:7733-7741, 2003
51. Zhang Y, Li L, Wang Y, Zhang J, Wei G, Sun Y, et al: Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma. Biochem Biophys Res Commun 358:124-129, 2007
52. Zhang ZH, Chen Y, Zhao HJ, Xie CY, Ding J, Hou YT: Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo. Cancer Biol Ther 6:587-595, 2007
53. Zhou Y, Song B, Qin WJ, Zhang G, Zhang R, Luan Q, et al: Heparanase promotes bone destruction and invasiveness in prostate cancer. Cancer Lett 268:252-259, 2008